NCT01664026

Brief Summary

To evaluate the effect of a 6-month web-based lifestyle modification program with and without telephone counseling versus usual care in obese patients with cardiovascular risk factors on:

  • Weight Loss
  • Waist circumference; blood pressure; total cholesterol, triglycerides, LDL-cholesterol, HDL-cholesterol; glucose and hemoglobin A1c; C-reactive protein.
  • Physical activity and eating habits
  • Quality of life

Trial Health

30
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Timeline
Completed

Started Aug 2012

Geographic Reach
1 country

1 active site

Status
withdrawn

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 1, 2012

Completed
8 days until next milestone

First Submitted

Initial submission to the registry

August 9, 2012

Completed
5 days until next milestone

First Posted

Study publicly available on registry

August 14, 2012

Completed
12 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2013

Completed
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2013

Completed
Last Updated

February 1, 2019

Status Verified

January 1, 2019

Enrollment Period

1 year

First QC Date

August 9, 2012

Last Update Submit

January 30, 2019

Conditions

Outcome Measures

Primary Outcomes (1)

  • Change in body weight from randomization to 6 months

    6 months

Secondary Outcomes (5)

  • Changes in waist circumference

    6 months

  • Changes in blood pressure

    6 months

  • Changes in lipid parameters (total cholesterol, triglycerides, LDL-cholesterol, HDL-cholesterol)

    6 months

  • Changes in glycemic parameters (glucose and hemoglobin A1c)

    6 months

  • Changes in C-reactive protein

    6 months

Other Outcomes (2)

  • Changes in lifestyle behaviors (physical activity and eating habits)

    6 months

  • Changes in quality of life

    6 months

Study Arms (3)

Control

NO INTERVENTION

Subjects assigned to the usual care group will receive general lifestyle recommendations as per their country standards of care.

Web

EXPERIMENTAL

Access to a web-based lifestyle modification program of 6-month duration that covers all aspects of a healthy lifestyle including physical activity, nutrition and weight maintenance.

Behavioral: Web-based lifestyle modification

Web+

EXPERIMENTAL

Access to a web-based lifestyle modification program of 6-month duration that covers all aspects of a healthy lifestyle including physical activity, nutrition and weight maintenance plus telephone counseling support by health coaches on a weekly or bi-weekly basis.

Behavioral: Web-based lifestyle modification +

Interventions

Access to a web-based lifestyle modification program of 6-month duration that covers all aspects of a healthy lifestyle including physical activity, nutrition and weight maintenance plus telephone counseling support by health coaches on a weekly or bi-weekly basis.

Web+

Eligibility Criteria

Age25 Years - 70 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Male or female 25-70 years of age
  • Obese (BMI ≥ 30 kg/m2 and \<40 kg/m2)
  • At least 2 cardiovascular risk factors (diabetes, hypertension or dyslipidemia) i) Hypertension defined by a history of hypertension, treatment of hypertension or BP values \>140/90 mmHg in two consecutive office visits ii) High cholesterol defined by an LDL-C ≥130 mg/dL and/or HDL-C \<40 mg/dL and triglycerides ≥150 mg/dL iii) Type 2 Diabetes Mellitus defined by a history of diabetes, treatment of diabetes or fasting glucose ≥126 mg/dL in two consecutive office visits
  • Participant must be willing and able to provide written informed consent
  • Participant must be willing and able to comply with study related procedures
  • Participant must have access to Internet and e-mail

You may not qualify if:

  • Stage 1 or 2 on Patient Activation Measures tool
  • Weight change of more than 5 kg during the 3 months preceding the screening visit
  • History of bariatric surgery
  • Fasting Plasma Glucose at screening \> 250 mg/dL (\> 13.9 mmol/L)
  • Hemoglobin A1c at screening \>8.5%
  • Treatment of type 2 diabetes with insulin (except for history of intermittent acute use, no more than 2 weeks usage in previous 6 months)
  • Uncontrolled or inadequately controlled hypertension at the time of screening with blood pressure \>160/100 mmHg
  • Secondary hypertension
  • Changes in lipid, blood pressure or diabetes modifying agents including introduction, change in dose or cessation in the 3 months prior to Screening Visit
  • Personal history of coronary heart disease, congestive heart failure, serious arrhythmias and stroke
  • Cardiovascular, hepatic, neurological, endocrine disease, active malignant tumor or other major systemic disease making implementation of the protocol or interpretation of the study results difficult.
  • Presence of any condition (medical, psychological, social, or geographical), actual or anticipated, that in the opinion of the Investigator would restrict or limit the patient's successful participation for the duration of the study
  • Presence of history of cancer within the past five years with the exception of adequately treated localized basal cell skin cancer or in situ uterine cervical cancer
  • Use of systemic glucocorticoids (excluding topical application or inhaled forms) for one week or more within 3 months prior to the time of screening
  • Use of any investigational agent (drug, biologic, device) within 3 months prior to screening

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Clinica Bazterrica

Buenos Aires, Argentina

Location

MeSH Terms

Conditions

Obesity

Condition Hierarchy (Ancestors)

OverweightOvernutritionNutrition DisordersNutritional and Metabolic DiseasesBody WeightSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Andres Digenio, MD

    STUDY DIRECTOR
0

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Jefe de Prevencion y Rehabilitacion

Study Record Dates

First Submitted

August 9, 2012

First Posted

August 14, 2012

Study Start

August 1, 2012

Primary Completion

August 1, 2013

Study Completion

December 1, 2013

Last Updated

February 1, 2019

Record last verified: 2019-01

Locations